(R)-3-[3-fluoro-4-(4-hydroxypiperidin-4-ylmethoxy)phenyl]-5-hydroxymethyloxazolidin-2-one
(R)-3-[3-fluoro-4-(4-hydroxypiperidin-4-ylmethoxy)phenyl]-5-hydroxymethyloxazolidin-2-one(1025097-55-5)
- Name: (R)-3-[3-fluoro-4-(4-hydroxypiperidin-4-ylmethoxy)phenyl]-5-hydroxymethyloxazolidin-2-one
- Synonyms:(R)-3-[3-fluoro-4-(4-hydroxypiperidin-4-ylmethoxy)phenyl]-5-hydroxymethyloxazolidin-2-one
- Molecular Formula:
- Molecular Weight:340.352
- CAS Registry Number:1025097-55-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1025097-55-5 (5R)-3-[3-fluoro-4-[(4-hydroxypiperidin-4-yl)methoxy]phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.1025097-55-5 (R)-3-(3-fluoro-4-((4-hydroxypiperidin-4-yl)methoxy)phenyl)-5-(hydroxymethyl)oxazolidin-2-one
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]

Other Product
- 1609240-48-3/4-(4-chlorophenyl)-5-ethyl-5-methyl-2-oxo-2,5-dihydro-1H-chromeno[4,3-b]pyridine-3-carbonitrile
- 1215118-58-3/2-(2-(3-cyano-4-isopropoxybenzyloxy)-6,7,8,9-tetrahydropyrido[1,2-a]indol-9-yl)acetic acid
- 1402927-17-6/ethyl 2-benzoyl-5-cyanopentanoate
- 1380677-17-7/2-cyano-1-(4-fluorophenyl)-3-(1-hydroxy-2,2,5,5-tetramethylpyrrolidin-3-yl)guanidine oxy radical
- 1315469-61-4/2,5-dichloro-4-[3-(4-cyclopropyl-3,4-dihydro-2H-quinoxaline-1-carbonyl)-pyridin-4-yloxy]-benzoic acid
- 503560-12-1/3-(4-hydroxymethyl-2-phenyl-4,5-dihydro-oxazol-5-yl)-N-methoxy-N-methyl-propionamide
- 274673-26-6/1-(3-bromopentyl)-4-(diphenylmethyl)piperazine
- 210644-10-3/2-[(3-hydroxyphenyl)methylene]-6-hydroxy-1-tetralone
- 278598-16-6/C20H30N2O
- 951161-56-1/2,3-dimethoxy-1-methyl-4-vinylbenzene
- 866367-95-5/(E)-(3S,7S,9S)-10-Benzyloxy-3,5,7,9-tetramethyl-dec-4-en-1-ol
- 1332337-67-3/4-methoxy-2,6,8-triphenylquinoline
- 1245773-29-8/(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-(1-(4-bromobenzyl)-1H-1,2,3-triazol-4-yl)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate
- 1187434-23-6/((2R,3S,4R,5R)-3-acetoxy-5-(2-amino-6-chloro-9H-purin-9-yl)-4-fluoro-3,4-dimethyltetrahydrofuran-2-yl)methyl benzoate
- 1236161-78-6/(7aS)-(-)-7a-benzyl-7,7a-dihydro-2-benzofuran-1,5(3H,6H)-dione
- 1178609-33-0/(3R,4S,4'R,5'R)-3-[4',5'-bis(methoxydiphenylmethyl)-1',3',2'-dioxaborolan-2'-yl]-6-methylhept-1-en-4-ol
- 874300-20-6/[(η5-C5H5)(PPh3)2Ru(-C2-C(Ph)2CH2Ph)]
- 123806-53-1/1,2-isopropyridene-3-(O-2,3,4,6-tetra-O-benzyl-D-glucopyranosyl)glycerol
- 953053-98-0/ethyl-(2E)-4-[[(4-methylphenyl)sulfonyl][2-[1-(1E)-[(phenylmethoxy)imino]ethyl]phenyl]amino]-2-butenoate
- 1025097-55-5/(R)-3-[3-fluoro-4-(4-hydroxypiperidin-4-ylmethoxy)phenyl]-5-hydroxymethyloxazolidin-2-one
- 1337989-80-6/(2S,3R,4R,5R)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)-1',4,4',5-tetrahydro-3H-spiro[furan-2,3'-pyrrolo[2,1-c][1,4]oxazine]-6'-carbaldehyde
- 1174556-66-1/methyl 7-methyl-6-oxo-2-(2-vinylbenzyl)octanoate
- 1294041-98-7/N-phenethylindoline-1-carboxamide
- 157363-98-9/Methanesulfonic acid (2R,3S,6S)-6-benzyloxy-2-methanesulfonyloxymethyl-3,6-dihydro-2H-pyran-3-yl ester
- 866755-93-3/C40H60Br2N4O8Si2
- 1201908-14-6/4'-butoxy-2-fluoro-3'-{[2-fluoro-4-(trifluoromethyl)phenylamido]methyl}biphenyl-4-carboxylic acid
- 1186506-51-3/C43H64N6O9
- 1421231-51-7/cyclohex-1-en-1-ylmethyl 2-[(tert-butyldimethylsilyl)oxy]-acetate
- 1570293-64-9/6-amino-2-neopentyl-2H-pyrazolo[3,4-d]pyrimidin-4(5H)-one
- 157367-55-0/4,4'-(hepta-1,6-diene-2,6-diyl)bis(methylbenzene)